Transl Clin Pharmacol.  2019 Mar;27(1):2-5. 10.12793/tcp.2019.27.1.2.

Expert clinical consulting for early drug development programs in Korea

Affiliations
  • 1CUREnCARE Research, Seoul 07345, Korea. hanlim.moon@curencareresearch.com

Abstract

No abstract available.


MeSH Terms

Korea*
Full Text Links
  • TCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr